IDENTIFYING AND RESPONDING TO POTENTIAL VIOLATIONS David Anderson David Anderson Healthcare Compliance Office, Internal Investigator Genentech, Inc. Dan.

Slides:



Advertisements
Similar presentations
4.02 Compliance Training Brian A. Dahl Senior Counsel Takeda Pharmaceuticals North America, Inc. November 14, 2003.
Advertisements

Pharmaceutical Congress Spring 2003 Preconference Symposia Compliance 101 for Pharmaceutical Manufacturers Michael P. Swiatocha June 8, 2003.
Chicago - March 29-30, PLUS Medical PL Symposium IMPACT OF SOCIAL MEDIA ON INSURANCE COMPANIES.
Pfizer Corporate Compliance Group ABA Section on International Law Spring Meeting April 15, 2005 Philip Weis Senior Corporate Counsel.
Environmental Management System (EMS)
This is an audio presentation Compliance Program Training for First Tier, Downstream and Related Entities.
BNSF Ethics and Compliance Program Roger Nober Executive Vice President Law and Secretary July 13, 2011.
Approaches to Operating a Compliance Program with a Small Compliance Department The Seventh Annual Pharmaceutical Regulatory and Compliance Congress Best.
THINGS TO CONSIDER BEFORE THE DOL COMES KNOCKING TONYA C. JORDAN SENIOR COUNSEL, LABOR AND EMPLOYMENT CONOCOPHILLIPS COMPANY Wage and Hour Litigation/Increased.
New HR Challenges in the Dynamic Environment of Legal Compliance By Teri J. Elkins.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
CORPORATE COMPLIANCE OVERVIEW David Meisels OSB Corporate Counsel Roundtable April 26, 2012.
Managing Business Ethics
Supplier Ethics: Program Checklist
Corporate Ethics Compliance *
WORKING WITH THIRD- PARTY VENDORS AND STRATEGIC PARTNERS Pharmaceutical Regulatory and Compliance Congress October Washington, D.C. David Davidovic,
Liability Protection Best Practices. ©SHRM 2008 Equal Employment Opportunity Commission – EEOC Created by Title VII of the 1964 Civil Right Act. Charged.
Minnesota Adoption of the Green Book April 16, 2015 Jo Kane Internal Control & Accountability Specialist.
EMPLOYEE USE OF COMPANY MONITORING & PRIVACY ISSUES.
October The Insider Financial Crime and Identity Theft Hacktivists Piracy Cyber Espionage and Sabotage.
© 2009 The McGraw-Hill Companies, Inc. All rights reserved. 1 McGraw-Hill Chapter 5 HIPAA Enforcement HIPAA for Allied Health Careers.
1 DELVACCA presents : The Ten Most Important Decisions to Make When Drafting a Code of Conduct.
CORPORATE COMPLIANCE Tim Timmons Vice President Compliance and Regulatory Services Health Future, LLC.
2012 Best Practices Forum June 20–22, 2012 The JW Marriott Washington, DC.
Developing and Implementing an Effective Compliance Program Mary Sacilotto,BA,CHC Chief Compliance Officer Alliance, Inc.
New FAR Ethics Requirements Richard W. Oehler Perkins Coie LLP 1201 Third Avenue Suite 4800 Seattle, WA (206)
Implementing International Codes of Conduct: The Daunting Issues and Questions Surrounding Global Compliance The Medical Device Regulatory, Reimbursement.
Managing the Privacy Function at a Large Company Kimberly S. Gray, Esq., CIPP Chief Privacy Officer Highmark Inc.
© 2013 Cengage Learning. All Rights Reserved. 1 Part Four: Implementing Business Ethics in a Global Economy Chapter 9: Managing and Controlling Ethics.
NABCA 19 TH ANNUAL LEGAL SYMPOSIUM ON ALCOHOL BEVERAGE LAW & REGULATION Erin L. Neff Senior Attorney Litigation and Regulatory Law Department March 6,
Manager ethics Business Ethics Infrastructure Slovak University of Technology Faculty of Material Science and Technology in Trnava.
Page 1 of 23 DMC’S COMMITMENT TO COMPLIANCE: COMPLIANCE PROGRAM CODE OF CONDUCT 2009 DMC Corporate Audit and Compliance Department Detroit Medical Center©
Pre-Conference III: Auditing, Monitoring and Effective Internal Investigations Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum.
Roadmap For An Effective Compliance And Ethics Program The Top Ten Things the Board Must Know [Name of Presenter] [Title] [Date]
From the it’s… Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum.
DOJ Perspectives on Effective Compliance and Investigations Maxwell Carr-Howard Husch Blackwell, LLP October 8, 2012.
Strategic Approaches to Improving Ethical Behavior
Implementing an Effective Global Anti-Bribery Program Implementing an Effective Global Anti-Bribery Program Elaine Murphy, MBA Director Health Care Compliance.
1 Records Management Organization The Committee provides guidance on operating the company’s records management program.
TITLE IX Title IX is 40+ years old and most of us know about its impact on gender equality in college sports; however, Title IX is not exclusive to athletics.
Copyright © 2015 Raytheon Company. All rights reserved. Customer Success Is Our Mission is a registered trademark of Raytheon Company. Fine Tuning Anti-Corruption.
Advanced Compliance Strategies Taking the Existing Compliance Program to Another Level Gary F. Giampetruzzi Pfizer Corporate Compliance November 14, 2003.
Flowers Hospital General Compliance Training-Students 2013.
Business Ethics: Ethics can be defined as standards or principles of conduct that govern the behavior of an individual or a group of individuals. Ethics.
Lilly Answers that Matter. Preserving the Value of Industry Interactions with Health Care Professionals Jack Harris, M.D. Vice President, U.S. Medical.
Building A Pharmaceutical Compliance Program Presentation to the Sixth Annual Congress on Health Care Compliance February 7, 2003 Janice Toran Fujisawa.
An Overview of Ethics. L E A R N I N G O B J E C T I V E S What is ethics, and why is it important to act according to a code of ethics? Why is business.
William Kolasky September 26, 2007 IMPLEMENTING AN EFFECTIVE ANTITRUST COMPLIANCE PROGRAM.
Key Social Media Considerations It is no longer a question of whether a social media policy is needed, it is more a matter of what that policy proscribes.
IMPLEMENTATION OF CORRECTIVE ACTION PLANS Karen Lowney Senior Director, Global Compliance Cephalon Elizabeth A. Lewis Vice President, Deputy General Counsel.
1 Compliance vs. the Law Department: How to Work Together Michael Dusseau Senior Director, Compliance North America Schering-Plough David Ralston, Esq.
0 Due Diligence Monitoring and Auditing of Third Party Vendors October 28, 2008 Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum.
1 Building a Compliance Program in a Small Cap Company The Seventh Annual Pharmaceutical Compliance and Best Practices Forum November 9, 2006 Colleen CravenJanice.
HOW TO AVOID COMMON DATA BREACH PITFALLS IAPP Privacy Academy 2014.
Insurance Regulatory Update Office of Corporate and Financial Regulation Joseph DiMemmo, CPA, Deputy Insurance Commissioner Corporate & Financial.
DELVACCA Presents… How to Conduct an Effective Internal Corporate Investigation: Avoid the Many Landmines May 6, 2010 ∙ Marriott Philadelphia Downtown.
2. Function and Responsibility
Roadmap For An Effective Compliance And Ethics Program
Respect in the Workplace
Epstein Becker & Green, P.C.
Is Your Ethics Program in Order?
Monitoring and Tracking in Companies with Small Compliance Departments
Complainant files complaint in person or through online reporting system to one of the entities defined by an arrow Bemidji State University Sexual Violence.
Chapter 8 Developing an Effective Ethics Program
Risk Management: why and how to protect your health center
Compliance, Ethics, and Audit
Neil Kirton and Zoë Newman
Complainant files complaint in person or through online reporting system to one of the entities defined by an arrow Bemidji State University and Northwest.
Pharmaceutical Congress: Responding to the Guidance
Presentation transcript:

IDENTIFYING AND RESPONDING TO POTENTIAL VIOLATIONS David Anderson David Anderson Healthcare Compliance Office, Internal Investigator Genentech, Inc. Dan Dovdavany Senior Corporate Counsel, US Litigation and Investigations Sanofi-Aventis Elizabeth A. Lewis Vice President, Deputy General Counsel Millennium Pharmaceuticals, the Takeda Oncology Company Wendy C. Goldstein (Moderator) Shareholder Epstein Becker & Green, P.C. OCTOBER 2008

DISCLAIMER The Statements Made By the Panelists during this Session Represent His/Her Individual Views and Should Not Be Construed to Represent those of his/her organization.

OVERVIEW IDENTIFYING POTENTIAL VIOLATIONS 1 RESPONDING TO POTENTIAL VIOLATIONS 2 DETERMINING CORRECTIVE ACTION 3

IDENTIFYING POTENTIAL VIOLATIONS Audience Polling Question In your opinion, what is the largest source of compliance reports that require an internal investigation? 1. Compliance hotline 2. Walk-ins / direct reports 3. Monitoring & auditing 4. External touches 1

IDENTIFYING POTENTIAL VIOLATIONS Audience Polling Question What do you believe is the biggest challenge facing Compliance departments for maintaining open lines of communication? 1. Overcoming employee resistance to report 2. Developing new ways to advertise the Compliance hotline 3. Convincing employees that the hotline is anonymous 4. Convincing employees that the company enforces a non- retaliation policy 1

IDENTIFYING POTENTIAL VIOLATIONS IDENTIFYING POTENTIAL VIOLATIONS DISCUSSION 1

RESPONDING TO POTENTIAL VIOLATIONS Audience Polling Question What do you believe is the biggest challenge facing Compliance departments when conducting an internal investigation? 1. Buy-in to the process from Management / Brand 2. Coordination between Compliance, Legal, HR, Business 3. Training employees to be effective investigators 4. Analyzing the legal implications to decide whether outside reporting is required 2

RESPONDING TO POTENTIAL VIOLATIONS Audience Polling Question True or False: Investigations of senior management should be handled differently? 1. True 2. False 2

RESPONDING TO POTENTIAL VIOLATIONS Audience Polling Question Fill in the Blank: Anonymous reports are ______ difficult to investigate than those reports in which the caller identifies him/herself. 1. More 2. Less 3. Equally 2

RESPONDING TO POTENTIAL VIOLATIONS Audience Polling Question Yes or No: A different protocol should be used for an internal investigation that is triggered by an “outside touch” than one that is triggered by an inside report. 1. Yes 2. No 2

RESPONDING TO POTENTIAL VIOLATIONS DISCUSSION 2

DETERMINING CORRECTIVE ACTION Audience Polling Question What do you believe is the biggest challenge facing Compliance departments when determining corrective action? 1. Ensuring consistency 2. Exercising discretion 3. Managing the interests of various parties 4. Deciding on appropriate corrective action for senior management 3

DETERMINING CORRECTIVE ACTION Audience Polling Question What department should be responsible for ensuring that consistent corrective action is determined? 1. Compliance department 2. Legal department 3. Human Resources department 4. Business 5. Other 3

DETERMINING CORRECTIVE ACTION DISCUSSION 3

IDENTIFYING AND RESPONDING TO POTENTIAL VIOLATIONS David Anderson David Anderson Healthcare Compliance Office, Internal Investigator Genentech, Inc. Dan Dovdavany Senior Corporate Counsel, US Litigation and Investigations Sanofi-Aventis Elizabeth A. Lewis Vice President, Deputy General Counsel Millennium Pharmaceuticals, the Takeda Oncology Company Wendy C. Goldstein (Moderator) Shareholder Epstein Becker & Green, P.C. OCTOBER 2008